Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
02/10/2000 | WO2000006204A2 Genetically engineered cells and tissues |
02/10/2000 | WO2000006193A1 Equine system for non-surgical artificial insemination |
02/10/2000 | WO2000006181A1 A medicament for treating recurrent ulcer of mouth and behcet's syndrome |
02/10/2000 | WO2000006180A1 Composition for stimulating the synthesis of the melanic pigment and process for obtaining it |
02/10/2000 | WO2000006178A1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
02/10/2000 | WO2000000825A3 Detection and modulation of cellular immunity to immune privileged antigens |
02/10/2000 | WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
02/10/2000 | WO1999045126A3 Enhanced prodrug activation |
02/10/2000 | DE19835368C1 Verfahren zur Herstellung einer Knorpelzellsuspension A process for the preparation of a cartilage cell suspension |
02/10/2000 | CA2356882A1 Graft versus host disease |
02/10/2000 | CA2338773A1 Ex vivo treatment of allogeneic and xenogeneic t-cells with gp39 antagonists |
02/10/2000 | CA2338194A1 Equine system for non-surgical artificial insemination |
02/10/2000 | CA2338001A1 Gastrointestinal bacterial antibody factories |
02/10/2000 | CA2336543A1 Isoforms of human calcium sensing receptor |
02/10/2000 | CA2336526A1 Composition for stimulating the synthesis of the melanic pigment and process for obtaining it |
02/10/2000 | CA2336490A1 Hematopoietic cell composition for use in transplantation |
02/10/2000 | CA2304596A1 A medicament for treating recurrent ulcer of mouth and behcet's syndrome |
02/09/2000 | EP0978559A2 Induction of tumour immunity by redirection of tumour cells against antigen presenting cells |
02/09/2000 | EP0977881A1 Expression of a modified foamy virus envelope protein |
02/09/2000 | EP0977880A2 Materials and methods for treatment of retinal diseases |
02/09/2000 | EP0977879A2 Eukaryotic gene expression cassette and uses thereof |
02/09/2000 | EP0977862A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
02/09/2000 | EP0977854A2 Truncated vegf-related proteins |
02/09/2000 | EP0977842A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
02/09/2000 | EP0977841A2 Materials and methods for ribozyme treatment of retinal diseases |
02/09/2000 | EP0977595A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers |
02/09/2000 | EP0977587A1 Chimeric flavivirus vaccines |
02/09/2000 | EP0977563A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
02/09/2000 | EP0977482A1 IDENTIFICATION OF POLYNUCLEOTIDES ENCODING NOVEL $i(HELICOBACTER) POLYPEPTIDES IN THE $i(HELICOBACTER) GENOME |
02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
02/09/2000 | EP0608313B1 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
02/09/2000 | CN1244215A Improved method for the production and purification of adenoviral vectors |
02/09/2000 | CN1244117A Cosmetic or dermo-phamaceutical products compatible with cutaneous ecology |
02/09/2000 | CN1243746A Oral liquid for treating piles |
02/09/2000 | CN1243744A 芦荟组合物 Aloe composition |
02/09/2000 | CN1243737A Medicinal capsule for treating stomach-ache |
02/09/2000 | CN1243735A Skin regrowing powder and its preparing process |
02/09/2000 | CN1243734A Medicine for treating rheumatic diseases |
02/09/2000 | CN1243732A Chinese medicine 'Baoeryin' and its preparing process |
02/09/2000 | CN1243722A Medicine for treating bone fracture and its preparing process |
02/09/2000 | CN1243716A Medicine for preventing and curing malignant tumor |
02/09/2000 | CN1243715A Medicine for treating piles and its preparing process |
02/09/2000 | CN1243714A Medicine for treating breast addiction and its preparing process |
02/09/2000 | CN1243713A Process for antistaling deer blood |
02/09/2000 | CN1243712A Process for preparing animal products containing disease-resistant factor by immunization |
02/09/2000 | CN1243711A Process for preparing deer products containing disease-resistant factor by immunization |
02/09/2000 | CN1243710A Medicine for treating esophageal obstruction caused by esophagus cancer and its preparing process |
02/09/2000 | CN1243703A Snake wine |
02/09/2000 | CN1049149C Liver cancer-curing oral liquid prepared with white ant as main material |
02/09/2000 | CN1049148C Stomach-recovering capsule |
02/09/2000 | CN1049143C Traditional Chinese medicine for curing anemia |
02/09/2000 | CN1049142C Qufushengjisan powder medicine capable of removing patrid tissues and promoting growth of new tissues and shengjisan powder |
02/09/2000 | CN1049141C Preparation method of traditional Chinese medicine sheet for bone joint |
02/09/2000 | CN1049139C Application of curing heart disease and preparing process thereof |
02/09/2000 | CN1049134C Chinese prepared medicine for curing apoplexy |
02/09/2000 | CN1049130C Medicine for treating myasthenia gravis 'Qiang-Ji-Ning' |
02/09/2000 | CN1049128C Antidiarrheal powder for baby |
02/09/2000 | CN1049127C Dysphagia ointment and its preparation method |
02/09/2000 | CN1049126C Buzheng zhuiguwang medicine for ischemic necrosis of fermoral head and preparing method thereof |
02/09/2000 | CN1049125C Health extract |
02/09/2000 | CN1049122C Multi-effect compound ointment for trauma |
02/09/2000 | CN1049119C Method for preparation of anti-B-hepatitis placental transfer factor |
02/09/2000 | CN1049118C High special transfer factor preparing process for B type hepatitis |
02/08/2000 | US6023009 Pancreatic islet cells capable of producing insulin, encapsulated within a semipermeable spheroidal membrane comprising agar gel. |
02/08/2000 | US6022899 Effective inhibitors of the cellular sodium proton antiporter |
02/08/2000 | US6022864 Nucleic acid respiratory syncytial virus vaccines |
02/08/2000 | US6022743 Organ tissue culture on a genetically engineered biocompatible framework; for forming tubular tissue structures, for gastrointestinal, genitourinary, blood vessel, hernia tissue, tendon and ligament repair |
02/08/2000 | US6022735 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
02/08/2000 | US6022692 Diagnosis of cancer in humans; screening sample with nucleotide sequences associated with cancer, hybridizing, the formation of hybridization complexes is indicative of cancer potential |
02/08/2000 | US6022538 Administering adriamycin or cisplatin, and cell therapy cells modified by in vitro treatment with a cytokine and gamma irradiation at a dose to irreversibly arrest cell proliferation but not interfere with the cytotoxic activity |
02/03/2000 | WO2000005395A1 Method for obtaining fatty acids from biomass by combined in-situ extraction, reaction and chromatography using compressed gases |
02/03/2000 | WO2000005394A1 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates |
02/03/2000 | WO2000005393A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
02/03/2000 | WO2000005343A2 Cell expansion system for use in neural transplantation |
02/03/2000 | WO2000004930A2 Method for inactivation of microorganisms using photosensitizers |
02/03/2000 | WO2000004911A1 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
02/03/2000 | WO2000004910A2 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
02/03/2000 | WO1999061052A3 Oral immunization with papillomavirus virus-like particles |
02/03/2000 | WO1999059506A9 Corporal tissue penile reconstruction |
02/03/2000 | DE19834814A1 Kosmetische und dermatologische Zubereitungen mit einem wirksamen Gehalt an Gallensäuren, ihren Salzen und/oder ihren Derivaten Cosmetic and dermatological preparations with an effective amount of bile acids, their salts and / or their derivatives |
02/03/2000 | DE19834430A1 Selbstdeletierende Vektoren für die Krebstherapie Selbstdeletierende vectors for cancer therapy |
02/03/2000 | DE19833738A1 Verfahren zur Isolierung von Krebszellen aus zellhaltigen Körperflüssigkeiten sowie Sets zur Durchführung dieses Verfahrens A method for isolating cancer cells from cell-containing body fluids, and kits for carrying out this method |
02/03/2000 | DE19832784A1 Continuous production of fatty acid esters from a biological source by contact with an inert catalyst |
02/03/2000 | CA2338068A1 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
02/02/2000 | EP0976759A2 Preparation of protein formulations with reduced content of aggregates |
02/02/2000 | EP0976399A1 Propolis extract |
02/02/2000 | EP0975786A2 Novel transgene expression system for increased persistence |
02/02/2000 | EP0975785A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3 |
02/02/2000 | EP0975782A1 Novel adenoviral vectors capable of facilitating increased persistence of transgene expression |
02/02/2000 | EP0975781A1 Molecular marker for muscle stem cells |
02/02/2000 | EP0975764A1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
02/02/2000 | EP0975756A1 Fibroblasts with a foreign gene-containing composition for treating wounds |
02/02/2000 | EP0975739A1 Stimulation, culture and preservation of pancreatic and other cells |
02/02/2000 | EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer |
02/02/2000 | EP0975665A1 Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
02/02/2000 | EP0975429A4 A centrifuge apparatus with temperature control means |
02/02/2000 | EP0975429A1 A centrifuge apparatus with temperature control means |
02/02/2000 | EP0975227A1 Topical use of probiotic bacillus spores to prevent or control microbial infections |
02/02/2000 | EP0975226A1 Cell-coated supports |
02/02/2000 | EP0975225A1 Fibrocyte-based cellular therapy formulations |